6-Month All-Oral Therapy Proves Effective for Treatment
A six-month oral regimen for rifampicin-resistant tuberculosis (RR-TB) has matched the efficacy of the standard nine-month treatment in Phase III trials, according to data published this week by Pharmastar. The ... Read More